Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    Molbio Diagnostics Has Spare Capacity. Can It Turn That Into Growth?

    2 days ago

    Molbio's proprietary test kits accounted for most product revenue in FY26, while unused manufacturing capacity offers room to grow. Government procurement cycles, overseas expansion and the company's valuation remain key factors to watch.
    Click here to Read More
    Previous Article
    Carlsberg Said To Near Public Filing For $700 Million India IPO
    Next Article
    Meta Touts AI Progress While Escalating Its Bet On The Market

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment